Glassman Wealth Services Horizon Therapeutics Public LTD CO Transaction History

Glassman Wealth Services

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 05, 2021	SELL	$71.83 - $95.48 $21,979 - $29,216	-306 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$67.0 - $84.39 $20,502 - $25,823	306 New	306 $22,000
Q2 2020 Aug 06, 2020	SELL	$30.2 - $56.98 $1,087 - $2,051	-36 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$24.87 - $38.56 $248 - $385	10 Added 38.46%	36 $1,000
Q4 2019 Feb 07, 2020	BUY	$25.43 - $36.67 $101 - $146	4 Added 18.18%	26 $1,000
Q2 2019 Aug 08, 2019	BUY	$22.81 - $28.48 $501 - $626	22 New	22 $1,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.